Germed Remedies Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2008.
2008 Delhi, Delhi, India Struck Off
Last Updated:
About Germed Remedies Limited

Germed Remedies Limited, a struck off public limited company, was established on 07 October 2008 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74120DL2008PLC184027. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Jitendra Kumar Agarwal (Director), Ankit Agarwal (Director), Rohan Agarwal (Director). Its latest AGM occurred on 24 September 2018, with the balance sheet filed on 31 March 2018. It is based at 1704, Iind Floor Bhagirath Palace, Delhi, Delhi, 110006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120DL2008PLC184027

  • Registration Number

    184027

  • Incorporation Date

    07 October 2008

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 17 Year, 4 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** %
Company report

Germed Remedies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Germed Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Germed Remedies Limited?
Current Directors
Name Designation Appointment Date Status
Jitendra Kumar Agarwal Director 07 Oct 2008 Current
Ankit Agarwal Director 07 Oct 2008 Current
Rohan Agarwal Director 07 Oct 2008 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Germed Remedies.

Germed Remedies Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Germed Remedies revenue growth over time
Germed Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Germed Remedies?

In 2018, Germed Remedies had a promoter holding of 62.00% and a public holding of 38.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Germed Remedies?

Unlock and access historical data on people associated with Germed Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Germed Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Germed Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Germed Remedies
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Germed Remedies Limited last Annual general meeting of members was held on 24 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    Germed Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Jitendra Kumar Agarwal was appointed as a Director was appointed as a Director on 07 Oct 2008 & has been associated with this company since 17 years 4 months . was completed.

  • Director Appointment

    The activity Ankit Agarwal was appointed as a Director was appointed as a Director on 07 Oct 2008 & has been associated with this company since 17 years 4 months . was completed.

  • Director Appointment

    Rohan Agarwal was appointed as a Director was appointed as a Director on 07 Oct 2008 & has been associated with this company since 17 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Germed Remedies Limited was registered on 07 Oct 2008 with Roc Delhi & aged 17 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Germed Remedies Limited?

The CIN of Germed Remedies Limited is U74120DL2008PLC184027.

Where is Germed Remedies Limited headquartered?

Germed Remedies Limited is headquartered at 1704, Iind Floor Bhagirath Palace, Delhi, Delhi, 110006.

When was Germed Remedies Limited incorporated?

Germed Remedies Limited was incorporated on 07 October 2008.

Who are the current directors of Germed Remedies Limited?

The current directors of Germed Remedies Limited are

What is the primary industry of Germed Remedies Limited?

The primary industry of Germed Remedies Limited is Pharma.

Is Germed Remedies Limited a listed company?

Germed Remedies Limited is unlisted.

What is the capital structure of Germed Remedies Limited?

The authorized capital of Germed Remedies Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available